2014
DOI: 10.1016/j.reprotox.2014.09.004
|View full text |Cite
|
Sign up to set email alerts
|

Effects of maternal dietary olive oil on pathways involved in diabetic embryopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
4
2
1

Relationship

2
5

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 55 publications
0
9
0
Order By: Relevance
“…Our previous studies performed in experimental models of diabetes and pregnancy have shown that a maternal EVOO dietary treatment regulates PPAR pathways and reduces proinflammatory markers in rat embryos, foetuses, placentas and in the offspring's heart 6,11‐13,15 . The dose of olive oil that shows these beneficial effects in animal models of diabetes and pregnancy provides half of the lipid‐derived calories (5% in an 11% lipid content diet).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Our previous studies performed in experimental models of diabetes and pregnancy have shown that a maternal EVOO dietary treatment regulates PPAR pathways and reduces proinflammatory markers in rat embryos, foetuses, placentas and in the offspring's heart 6,11‐13,15 . The dose of olive oil that shows these beneficial effects in animal models of diabetes and pregnancy provides half of the lipid‐derived calories (5% in an 11% lipid content diet).…”
Section: Discussionmentioning
confidence: 99%
“…PPARs are nutrigenomic agents, being monounsaturated fatty acids (MUFAs, the main components of olive oil), PPARs endogenous ligands 9,10 . In experimental models of diabetes and pregnancy, our previous studies have shown that diets enriched in extra virgin olive oil (EVOO) lead to antiinflammatory effects, as shown by the ability of these diets to prevent increased levels of proinflammatory cytokines, nitric oxide overproduction, and matrix metalloproteinases (MMPs) overexpression in placentas, embryos and different foetal organs 11‐16 . Studies have also shown that although maternal EVOO‐dietary treatments do not prevent programming of metabolic diseases in the offspring of diabetic animals, this treatment reduces the levels of proinflammatory markers in the offspring's heart and prevents hypertriglyceridemia in the adult offspring of diabetic rats 11,16 …”
Section: Introductionmentioning
confidence: 99%
“…The mRNA levels of Cox, Nrf1, Tfam, Pparδ and Pgc-1α were evaluated by semi-quantitative reverse transcription polymerase chain reaction (RT-PCR), as previously described (Higa et al, 2014). Four pooled embryos from each rat in each experimental group (n = 9) were kept in RNAlater® (Ambion, Texas, USA) at −20°C and RNA was extracted with RNAzol (Molecular Research Center, Cincinnati, USA) in accordance with the manufacturer's instructions.…”
Section: Analysis Of Mrna Levels Of Cox Nrf1 Tfam Pparδ and Pgc-1αmentioning
confidence: 99%
“…The nuclear receptor PPARδ participates in cell proliferation and differentiation in adult tissue as well as in fetal tissues and has antiinflammatory properties (Coll et al, 2010;Rotman et al, 2006). We have previously found that aberrant PPARδ signalling is involved in embryo dysmorphogenesis and that PPARδ is reduced in embryos from severe diabetic rats (Higa et al, 2007(Higa et al, , 2014. In the present study, we also found reduced Pparδ mRNA levels in the embryos from mild diabetic rats and that idebenone was able to modulate Pparδ transcription, increasing the reduced mRNA levels of this nuclear receptor.…”
Section: Article In Pressmentioning
confidence: 99%
“…Some placental defects in PPARγ and PPARδ null mice results in the death of 27 embryos indicating these forms are essential, and their absence via other PPAR isoforms rescue adverse phenotype (Wang et al, 2007;Barak et al, 2008). Previous literature reveals that decreased embryonic PPARδ and decidual PPARγ in diabetic rats during early organ development related to compromised embryo morphogenesis (Higa et al, 2010;Higa et al, 2014). Moreover, alterations in the fatty acid metabolism consist of massive crosstalk between PPAR and mTOR in different cell types have been documented (Blanchard et al, 2012;Angela et al, 2016) and all these nutrient pathways share target with fatty acid-binding protein-4 (FABP4) (Wang et al, 2017).…”
Section: Peroxisome Proliferator-activated Receptors (Ppars)mentioning
confidence: 99%